| |
Tuesday, October 29, 2024 | 2pm ET / 11am PT Fraud, waste, and abuse (FWA) cost healthcare payers billions every year, negatively impacting operational efficiencies. This webinar will provide actionable insights and tools to strengthen your organization’s defenses against FWA. Discover how to detect, prevent, and effectively combat these issues. Don't miss out, register now. 
|
|
| By Noah Tong UnitedHealth and Humana saw star ratings decrease, whereas insurtechs celebrated their scores. We break down how all major insurers—and their investors—are reacting. |
|
|
|
By Anastassia Gliadkovskaya,Sam Donndelinger Ending the HIV epidemic hinges on both treatment and prevention, particularly through access to PrEP. For at-risk individuals living in the U.S. South—where HIV is a daunting reality—PrEP use is very low compared to the number of new HIV cases. |
By Emma Beavins The third temporary extension is rumored to be for just one year, punting the deadline for the next administration to negotiate permanent rules to December 2025. Telemedicine companies, including those that prescribe Adderall, will be able to continue prescribing as they have since 2020. |
By Paige Minemyer UnitedHealth Group kicked off another round of earnings calls for major health insurance companies on Tuesday morning, where it reported $6 billion in profit for the third quarter of 2024. |
|
Tuesday, October 29, 2024 | 2pm ET / 11am PT The US is grappling with a maternal health crisis, marked by distressingly high morbidity and mortality rates, particularly within underserved communities. Join us for an important session that will provide actionable strategies to bridge these gaps, improve health outcomes, and revolutionize maternal healthcare. Register now. 
|
|
By Paige Minemyer It's a tumultuous time at industry giant CVS Health, and on Friday the company revealed a shake-up at the top that now has David Joyner stepping in as CEO. |
By Heather Landi Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore chain's ongoing turnaround strategy amid a rocky fiscal 2024. |
By Noah Tong A report from Sen. Richard Blumenthal, D-Connecticut, found that the country's biggest Medicare Advantage insurers use artificial intelligence to control costs and deny prior auth claims. |
By Paige Minemyer Blue Cross Blue Shield plans have agreed to a $2.8 billion settlement to resolve legal allegations from a slew of providers who claim the insurers colluded to prevent competition and lower reimbursements. |
By Dave Muoio Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence have committed "tens of millions of dollars a year" to Longitude Health, a springboard for new for-profit operating companies. |
By Heather Landi Microsoft recently unveiled several new AI capabilities for healthcare organizations designed to help analyze diverse medical data, streamline nursing documentation and enable companies to build their own healthcare AI agents. |
Fierce podcasts Don’t miss an episode |
| This week on "Podnosis," reporters discuss HIV’s impact in the South, inequitable access to PrEP and share stories from affected patients. |
|
|---|
|
|
|
As healthcare costs continue to rise, it's essential to adopt a comprehensive approach that encompasses network and benefit design, clinical programs and member engagement. Join us for this insightful webinar to explore actionable solutions to improve cost-efficiency and employee health with practical strategies. Register now. 
|
|
Whitepaper As the hospital price transparency deadline looms, hospitals that leverage the proper technology and commit to consistent monitoring can avoid costly errors and remain compliant, avoiding hefty fines, and a loss of patient confidence that can negate community trust. Sponsored by: Health Catalyst |
Whitepaper Discover how MultiPlan’s Payment Integrity solutions are helping payors navigate the complex industry landscape. Sponsored by: MultiPlan |
Whitepaper Prostate cancer is one of the most diagnosed malignancies in men and the second leading cause of cancer mortality. However, treatment decisions depend on several critical factors. This white paper discusses the importance of risk stratification, the role of patient life expectancy, and the latest treatment options available, including radical prostatectomy and radiotherapy Sponsored by: MCG Health |
| The Lighthouse at Pier 61 in New York City |
|
|
| |
|
